Jun 6 2022, ASCO Poster, Melanoma

Glycoproteomics as a powerful liquid biopsy-based predictor of checkpoint-inhibitor treatment benefit in metastatic malignant melanoma


Learn More →
Jun 5 2022, ASCO Poster, Sarcoma

Serum glycoproteomic signatures predict overall survival in bone and soft tissue sarcoma patients treated with immune checkpoint inhibitor therapy


Learn More →
Jun 5 2022, ASCO Online Publication, Immune Checkpoint Inhibitors

Clinicians’ perspective on use of immune checkpoint inhibitors and related biomarkers for solid tumors


Learn More →
Jun 2 2022, ASCO Online Publication, Ovarian Cancer

Liquid-biopsy-derived Glycoproteomic Profiling as a Novel Means for Noninvasive Diagnosis of Ovarian Cancer.


Learn More →
Jun 2 2022, ASCO Online Publication, Non-Small Cell Lung Cancer

Glycoproteomics as a powerful liquid biopsy-based screening tool for non-small cell lung cancer.


Learn More →
Jun 2 2022, ASCO Online Publication, Breast Cancer

Predicting breast cancer in women using liquid biopsy-derived glycoproteomic markers.


Learn More →